Clinical Trial Update: Efficacy and Safety of HEP-40 Chitosan for Mild to Moderately Elevated Cholesterol [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the efficacy and safety of HEP-40 Chitosan in patients with hypercholesterolemia have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• HEP-40 Chitosan

Snippet

Sponsor: DNP Canada | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED